Select Country

 
877-783-6728 (877-StemSave)

StemSave Blog

Sickle Cell Disease Treated with Stem Cells

Posted by devin@stemsave.com on Jul 26, 2014 10:01:14 AM

Patients with sickle cell anemia have utilized stem cells from their siblings to treat the disease.

Researchers led by Matthew Hsieh of the National Institute of Diabetes and Digestive and Kidney Diseases and the National Heart, Lung, and Blood Institute have reversed sickle cell disease in adults by utilizing stem cells from the patients’ siblings. The patients received a transplant that combined their own stem cells with those of a sibling, resulting in an increase in lung function and a decrease in the patients’ sickle cell count, as well as their dependency on immunosuppressant and pain relieving drugs.

Read More

Topics: sickle cell disease, stemsaveblog, clinical trials, Debilitating Diseases, Stemcells, autologousstemcells

Stem Cell Clinical Trials to Treat Genetic Disorders Announced

Posted by pamela@stemsave.com on Aug 1, 2013 8:03:20 AM

Gene therapies utilizing stem cells are being developed that may lead to a cure for several genetic diseases. Currently, two clinical trials were announced to treat Cerebral Adrenoleukodystrophy (CCALD) and beta-thalassemia/sickle cell disease.

Read More

Topics: sickle cell disease, Phase III, stemsaveblog, Cerebral Adrenoleukodystrophy, clinical trials, Beta-thalassemia, Stemcells, translational genomics, autologousstemcells, young stem cells

Stem Cell Treatments for Hematological Malignancies Advance to Clinical Testing Phase

Posted by devin@stemsave.com on Oct 15, 2012 6:30:14 AM

Gamida Cell, a leading adult stem cell therapeutics company has completed enrollment for a Phase I/II trial for hematological malignancies utilizing their NiCord treatment. The treatment is a potential cure for blood cancers, sickle cell disease, thalassemia, severe autoimmune diseases and metabolic diseases. This trial is but one example of the increasing number of stem cell treatments moving out of the lab and entering the clinical testing phase.

Read More

Topics: sickle cell disease, Phase III, Blood Cancer, stemsaveblog, clinical trials, Stemcells, hematological malignancies

AAOMS

AAOMS - American Association of Oral and Maxillofacial Surgeons

 

As the industry leader, StemSave is the only stem cell banking service to be designated as an ASI approved program.

Subscribe to Email Updates

Join our Newsletter

Posts by Topic

see all